0001493152-24-001076.txt : 20240104
0001493152-24-001076.hdr.sgml : 20240104
20240104160545
ACCESSION NUMBER: 0001493152-24-001076
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231228
FILED AS OF DATE: 20240104
DATE AS OF CHANGE: 20240104
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hrkac Frederick
CENTRAL INDEX KEY: 0001933130
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38659
FILM NUMBER: 24511817
MAIL ADDRESS:
STREET 1: C/O BIOSIG TECHNOLOGIES
STREET 2: 55 GREENS FARMS ROAD
CITY: WESTPORT
STATE: CT
ZIP: 06880
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BioSig Technologies, Inc.
CENTRAL INDEX KEY: 0001530766
STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 264333375
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 55 GREENS FARMS ROAD
CITY: WESTPORT
STATE: CT
ZIP: 06880
BUSINESS PHONE: (203) 409-5444
MAIL ADDRESS:
STREET 1: 55 GREENS FARMS ROAD
CITY: WESTPORT
STATE: CT
ZIP: 06880
4
1
ownership.xml
X0508
4
2023-12-28
0
0001530766
BioSig Technologies, Inc.
BSGM
0001933130
Hrkac Frederick
C/O BIOSIG TECHNOLOGIES, INC.
55 GREENS FARMS ROAD
WESTPORT
CT
06880
1
0
0
0
0
Stock Option (Right to Buy)
0.4742
2023-12-28
4
A
0
600000
0
A
2033-12-27
Common Stock
600000
600000
D
Restricted Stock Units
2023-12-28
4
A
0
900000
0
A
Common Stock
900000
900000
D
One hundred thousand (100,000) of the shares of common stock underlying the stock option shall vest on each monthly anniversary of the date of grant for six consecutive months, provided that the Reporting Person is still providing services to the issuer or a subsidiary on such vesting dates.
Each restricted stock unit ("RSU") represents the right to receive, at settlement, one (1) share of common stock.
This RSU award was granted on December 28, 2023. Upon the issuer's market valuation of $50,000,000, three hundred thousand (300,000) RSUs shall vest and upon the issuer's market valuation of $100,000,000, six hundred thousand (600,000) RSUs shall vest, subject to the terms and conditions of the BioSig Technologies, Inc. 2023 Long-Term Incentive Plan and the issuer's standard form of Restricted Stock Unit Award Agreement, provided that the Reporting Person is still providing services to the issuer or a subsidiary on such vesting dates. Notwithstanding the foregoing, upon the occurrence of (i) a change in control, or (ii) a termination of service due to death or total and permanent disability, all unvested RSUs shall immediately become vested RSUs.
/s/ Kenneth Londoner, attorney-in-fact
2024-01-04